• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A research on the influence of two herbal concoctions on Toll-like receptor signal pathways of influenza virus induced pneumonia in mice].

tetano

Editor, Senior Moderator
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 May;26(5):321-4. doi: 10.3760/cma.j.issn.2095-4352.2014.05.007.
[A research on the influence of two herbal concoctions on Toll-like receptor signal pathways of influenza virus induced pneumonia in mice].
[Article in Chinese]
Liu Q1, Wang J, Ma Y, Gu L.
Author information
Abstract
OBJECTIVE:

To investigate the effect of Shufeng Xuanfei and Jiebiao Qingli concoctions on Toll-like receptor (TLR) signal pathway of pneumonia infected with influenza virus in mice.
METHODS:

The pneumonia model was reproduced by nasal dropping of influenza virus A in mice. The mice were randomly divided into nine groups: normal group (C), model group (M), tamiflu group (D), Shufeng Xuanfei low-dose (SL), medium-dose (SM) and high-dose (SH) groups, Jiebiao Qingli low-dose (JL), medium-dose (JM) and high-dose (JH) groups, each n=12. Two hours after model-reproduction, the mice in C group and M group received distilled water by gavage. The mice in D group received 2.5 g?mL(-1)?d(-1) oseltamivirphosphate. Shufeng Xuanfei formula in doses of 3.76, 1.88, 0.94 g?kg(-1)?d(-1) were respectively administered to SH, SM and SL groups by gavage, Jiebiao Qingli formula in doses of 4.37, 2.18, 1.09 g?kg(-1)?d(-1) was given to JH, JM and JL groups by gavage, respectively. Each group was in equal dose of 0.2 mL daily over a 4-day period. Total RNA was extracted in each group. Then gene chips were used to screen these RNA samples. Some genes that were involved in TLR signal pathways were selected. These candidate genes were verified by real-time reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS:

TLR7, MYD88, CCL5, IFNB1, IL6, IL12a, NFKBIA and IKBKB were up-regulated in model group compared with control group. Compared with model group, down-regulated genes in medium-dose, low-dose Shufeng Xuanfei formula and medium-dose Jiebiao Qingli formula included TLR3, TLR7, MYD88, CCL5, IFNB1, IL6, IL12a, NFKBIA and IKBKB (log2 signal intensity of SM/M in medium-dose Shufeng Xuanfei formula group were -1.24, -2.02, -1.36, -1.95, -0.63, -1.33, -3.50, -1.33, -1.33, log2 signal intensity of SL/M in low-dose Shufeng Xuanfei group were -1.07, -2.43, -2.63, -2.30, -5.09, -3.19, -3.53, -1.95, -1.95, log2 signal intensity of JM/M in medium-dose Jiebiao Qingli formula group were -1.78, -0.55, -1.35, -1.47, -1.65, -2.03, -3.02, -1.57, -1.57, respectively). The results suggested that the effect of Shufeng Xuanfei formula was better than that of Jiebiao Qingli formula. By RT-PCR, compared with model group, low-dose, medium-dose and high-dose groups of Shufeng Xuanfei formula, medium-dose and high-dose groups of Jiebiao Qingli formula, and tamiflu group, significant decrease in TLR7, nuclear factor-ΚB (NF-ΚB), myeloid differential protein-88 (MyD88) mRNA expression were found. Medium-dose and low-dose Shufeng Xuanfei formula group (TLR7 mRNA: 3.6?0.3, 3.5?1.2 vs. 7.4?1.6, NF-ΚB mRNA: 1.1?0.2, 1.0?0.2 vs. 2.2?0.4; MyD88 mRNA: 1.4?0.4, 1.0?0.3 vs. 3.4?0.9, all P<0.01) and medium-dose Jiebiao Qingli formula group (TLR7 mRNA: 4.9?0.3 vs. 7.4?1.6, NF-ΚB mRNA: 1.3?0.7 vs. 2.2?0.4, MyD88 mRNA: 1.6?0.8 vs. 3.4?0.9, P<0.05 or P<0.01) were shown statistically significant decreases compared with the model group.
CONCLUSIONS:

Medium-dose and low-dose Shufeng Xuanfei formula and medium-dose Jiebiao Qingli formula can inhibit the inflammatory reaction induced by influenza virus by down-regulating the NF-ΚB through TLR signal pathways dependent on MyD88. The regulation of Shufeng Xuanfei formula in TLR signal pathways was superior to that of Jiebiao Qingli formula.

PMID:
24809260
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24809260
 
Back
Top Bottom